Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
Shoenfeld
Y
Y
Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Israel.
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000276:immunology; D003029:Coagulants / Q000276:immunology*; D004195:Disease Models, Animal; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007114:Immunization; D007130:Immunoglobulin Idiotypes / Q000032:analysis*; D051379:Mice; D008807:Mice, Inbred BALB C; D010978:Platelet Factor 4 / Q000276:immunology*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology
D000925:Anticoagulants; D001323:Autoantibodies; D003029:Coagulants; D006495:Heparin, Low-Molecular-Weight; D007130:Immunoglobulin Idiotypes; D010978:Platelet Factor 4; D006493:Heparin